AARP on its latest drug price campaign: ‘There’s a lot of anger out there’
The organization has fighting words for Big Pharma.
Drug Pricing
4 takeaways from the PBM drug-price hearing on Capitol Hill
PBM execs were grilled on transparency, rebates and mega-mergers during Tuesday’s Senate Finance Committee hearing.
Live blog: PBMs face congressional grilling
The latest from the Senate Finance Committee’s grilling of executives from Cigna, CVS Health and CVS Caremark, Humana and OptumRx
Continued research depends on fair prices for treatments
Sander Flaum explains why continued research depends on fair prices for treatments.
Eli Lilly, Johnson & Johnson take initiative, get in front of PhRMA guidelines
Eli Lilly and Johnson & Johnson take the lead on PhRMA’s new guidelines for DTC ads.
First TV drug ad featuring list price debuts today
The spot for Johnson & Johnson blood thinner Xarelto comes ahead of a rule, proposed by the Trump administration in October, which would require drugmakers to disclose list prices in TV ads. The rule faces opposition from trade group PhRMA.
Expect legislative baby steps, not big leaps on drug prices
Even though both parties agree on lowering drug prices, experts predict changes will be incremental.
4 takeaways from Tuesday’s Senate drug pricing hearing
Seven pharma executives were grilled on drug prices on Capitol Hill on Tuesday.
Live blog: Pharma execs on the Hill
The latest from the Senate Finance Committee’s grilling of pharma executives on Capitol Hill.
Clarity in DTC TV ad drug pricing
Belle Frank is chief strategy officer, global health practice at VMLY&R.
